Opportunity ID: 282700

General Information

Document Type: Grants Notice
Funding Opportunity Number: RFA-FD-16-029
Funding Opportunity Title: Bioequivalence of Topical Products: Comparing Epidermal Pharmacokinetics by Spectroscopic Imaging Techniques (U01)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Cooperative Agreement
Category of Funding Activity: Consumer Protection
Food and Nutrition
Health
Category Explanation:
Expected Number of Awards: 2
Assistance Listings: 93.103 — Food and Drug Administration_Research
Cost Sharing or Matching Requirement: No
Version: Synopsis 1
Posted Date: Apr 01, 2016
Last Updated Date:
Original Closing Date for Applications: Jun 03, 2016
Current Closing Date for Applications: Jun 03, 2016
Archive Date: Jul 03, 2016
Estimated Total Program Funding: $500,000
Award Ceiling: $250,000
Award Floor:

Eligibility

Eligible Applicants: Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
For profit organizations other than small businesses
County governments
Native American tribal organizations (other than Federally recognized tribal governments)
Private institutions of higher education
Others (see text field entitled “Additional Information on Eligibility” for clarification)
Small businesses
Public and State controlled institutions of higher education
City or township governments
Independent school districts
Special district governments
Native American tribal governments (Federally recognized)
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
State governments
Public housing authorities/Indian housing authorities
Additional Information on Eligibility: Non-domestic (non-U.S.) Entities (Foreign Institutions) are eligible to apply.
Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply.
Foreign components, as defined in the HHS Grants Policy Statement, are allowed.

Additional Information

Agency Name: Food and Drug Administration
Description: The purpose of this funding opportunity is to support the research and development necessary to advance spectroscopic imaging technologies, methods, study designs, and analyses to non-invasively measure the rate and extent to which a topically applied compound becomes available in the epidermis, at or near a site of action within the skin. The expectation is that the funded work will produce an accurate, sensitive and reproducible approach that measures the amount of drug present in the epidermis at each of a series of depths below the skin surface, which can be utilized to monitor epidermal pharmacokinetics by repeated measurements over time.
Link to Additional Information: full announcement of RFA-FD-16-029
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

Eric Bozoian

Grants Management Specialist

Phone 2404027623
Email:eric.bozoian@fda.hhs.gov

Version History

Version Modification Description Updated Date

Related Documents

Packages

Agency Contact Information: Eric Bozoian
Grants Management Specialist
Phone 2404027623
Email: eric.bozoian@fda.hhs.gov
Who Can Apply: Organization Applicants

Assistance Listing Number Competition ID Competition Title Opportunity Package ID Opening Date Closing Date Actions
93.103 PKG00222308 Apr 04, 2016 Jun 03, 2016 View

Package 1

Mandatory forms

282700 RR_SF424_2_0-2.0.pdf

282700 PHS398_CoverPageSupplement_3_0-3.0.pdf

282700 RR_OtherProjectInfo_1_3-1.3.pdf

282700 PerformanceSite_2_0-2.0.pdf

282700 RR_KeyPersonExpanded_2_0-2.0.pdf

282700 RR_Budget_1_3-1.3.pdf

282700 PHS398_ResearchPlan_3_0-3.0.pdf

Optional forms

282700 RR_SubawardBudget30_1_3-1.3.pdf

282700 PHS_Inclusion_Enrollment_Report-1.0.pdf

282700 PHS_AssignmentRequestForm-1.0.pdf

2025-07-09T11:40:10-05:00

Share This Post, Choose Your Platform!

About the Author: